|
|
Article: Rozerem gets FDA approval as treatment for insomnia.(Takeda Pharmaceuticals North America Inc.)(Brief Article)
- Article from:
- Chain Drug Review
- Article date:
- August 29, 2005
CopyrightCOPYRIGHT 2005 Racher Press, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The Food and Drug Administration has approved a new insomnia treatment. Manufacturer Takeda Pharmaceuticals Inc. says the product, Rozerem, the first prescription sleep aid not designated as a controlled substance, will be available late next month. It ...
Related newspaper, magazine, and journal articles:
|
|
Article: Duetact given FDA approval as treatment for ...
Chain Drug Review;
August 28, 2006 ;
690 words
... ... The new product offers two commonly used doses (pioglitazone HCl and glimepiride) in a single tablet. Takeda Pharmaceuticals North America Inc. developed the innovative product. Takeda expects the medication to be available later ...
|
|